About 1 result found for searched term "2851885-95-3" (0.129 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M50170 | ARV-393 | PROTAC |
| ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
